B-cell activation in patients with irritable bowel syndrome (IBS)

Neurogastroenterology and Motility

Volumn 21, Issue 6, 2009, Pages

  Ohman L ^a,b,c   Lindmark, A C ^c   Isaksson, S ^c   Posserud, I ^b   Strid, H ^b   Sjovall H ^b   Simren M ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Immune activation; Irritable bowel syndrome; Lipopolysaccharide; Lymphocyte; Probiotics

Indexed keywords

B7 ANTIGEN; BETA7 INTEGRIN; CD86 ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDE; PROBIOTIC AGENT;

ADULT; ARTICLE; B LYMPHOCYTE ACTIVATION; BIFIDOBACTERIUM ANIMALIS; BLOOD SAMPLING; CELL CULTURE; CELL ISOLATION; CELL SURFACE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; IRRITABLE COLON; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PARACASEI; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; ULTRAVIOLET RADIATION;

ADULT; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD40; ANTIGENS, CD80; ANTIGENS, CD86; B-LYMPHOCYTES; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; GRAM-POSITIVE BACTERIA; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULIN G; INTEGRIN BETA CHAINS; IRRITABLE BOWEL SYNDROME; LEUKOCYTE COUNT; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PHENOTYPE; PROBIOTICS; STIMULATION, CHEMICAL; YOUNG ADULT;

EID: 65949087893     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2009.01272.x     Document Type: Article

References (29)

1. Parry SD., Stansfield R, Jelley D et al. Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective, community-based, case-control study. Am J Gastroenterol 2003 98 : 1970 5. (Pubitemid 37185791)
2. Parry SD, Stansfield R, Jelley D et al. Is irritable bowel syndrome more common in patients presenting with bacterial gastroenteritis? A community-based, case-control study. Am J Gastroenterol 2003 98 : 327 31. (Pubitemid 36232381)
3. Simrén M, Axelsson J, Gillberg R, Abrahamsson H, Svedlund J, Björnsson ES. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 2002 97 : 389 96. (Pubitemid 34160766)
4. Dinan TG, Quigley EM, Ahmed SM et al. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology 2006 130 : 304 11. (Pubitemid 43202030)
5. Liebregts T, Adam B, Bredack C et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007 132 : 913 20. (Pubitemid 46440872)
6. Chadwick VS, Chen W, Shu D et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002 122 : 1778 83. (Pubitemid 34651421)
7. Dunlop SP, Jenkins D, Neal KR, Spiller RC. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 2003 125 : 1651 9. (Pubitemid 37500429)
8. Dunlop SP, Jenkins D, Spiller RC. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol 2003 98 : 1578 83. (Pubitemid 36875351)
9. Dunlop SP, Jenkins D, Neal KR et al. Randomized, double-blind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 2003 18 : 77 84. (Pubitemid 36897983)
10. + blood T lymphocytes in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2005 3 : 980 6. (Pubitemid 41415745)
11. Spiller RC, Jenkins D, Thornley JP et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000 47 : 804 11.
12. Atkinson W, Sheldon TA, Shaath N, Whorwell PJ. Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut 2004 53 : 1459 64. (Pubitemid 39265266)
13. Zar S, Mincher L, Benson MJ, Kumar D. Food-specific IgG4 antibody-guided exclusion diet improves symptoms and rectal compliance in irritable bowel syndrome. Scand J Gastroenterol 2005 40 : 800 7. (Pubitemid 40978855)
14. Zar S, Benson MJ, Kumar D. Food-specific serum IgG4 and IgE titers to common food antigens in irritable bowel syndrome. Am J Gastroenterol 2005 100 : 1550 7. (Pubitemid 41032362)
15. Zuo XL, Li YQ, Li WJ et al. Alterations of food antigen-specific serum immunoglobulins G and E antibodies in patients with irritable bowel syndrome and functional dyspepsia. Clin Exp Allergy 2007 37 : 823 30. (Pubitemid 47074558)
16. Rodriguez-Pinto D. B cells as antigen presenting cells. Cell Immunol 2005 238 : 67 75.
17. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999 45 (Suppl. 2 II43 7. (Pubitemid 29434812)
18. Gonsalkorale WM, Miller V, Afzal A, Whorwell PJ. Long term benefits of hypnotherapy for irritable bowel syndrome. Gut 2003 52 : 1623 9. (Pubitemid 37363448)
19. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997 11 : 395 402. (Pubitemid 27183522)
20. Öhman L, Simrén M. New insights into the pathogenesis and pathophysiology of irritable bowel syndrome. Dig Liver Dis 2007 39 : 201 15. (Pubitemid 46196435)
21. Posserud I, Stotzer PO, Björnsson ES, Abrahamsson H, Simrén M. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007 56 : 802 8. (Pubitemid 46854194)
22. Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000 95 : 3503 6.
23. Si JM, Yu YC, Fan YJ, Chen SJ. Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol 2004 10 : 1802 5.
24. Malinen E, Rinttila T, Kajander K et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005 100 : 373 82. (Pubitemid 40314522)
25. Pentcheva-Hoang T, Egen JG, Wojnoonski K, Allison JP. B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity 2004 21 : 401 13. (Pubitemid 39208341)
26. Egen JG, Kuhns MS, Allison JP. CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat Immunol 2002 3 : 611 8. (Pubitemid 34752469)
27. Acuto O, Michel F. CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nat Rev Immunol 2003 3 : 939 51. (Pubitemid 37521536)
28. Öhman L, Lindmark A-C, Isaksson S et al. Dysfunctional T cell responses after polyclonal stimulation in patients with irritable bowel syndrome (IBS). Gastroenterology 2008 134 : A41.
29. Simrén M, Månsson A, Langkilde AM et al. Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion 2001 63 : 108 15. (Pubitemid 32221204)